Johns Hopkins was at a pivotal inflection point as a leader in groundbreaking research and clinical excellence. As their Precision Medicine Analytics Platform (PMAP) continues to progress and cultivate new centers of excellence for discovery, a new era of data science and deep learning is developing at one of the most prestigious research and clinical institutions in the world. The outlook for diagnosis, disease prevention, personalized treatments and medical standards is being transformed.

But discoveries are only the first step of the transformation. They must be translated into commercial solutions that can be scaled and adopted across the continuum of care. 

As Johns Hopkins prepared for the J.P Morgan Healthcare conference in January 2021, they needed to define a differentiating story from other startups and research institutions and attract an audience much different than the traditional patient and physician groups.

They needed to attract the investor community. 

THE CAMPAIGN

Engineering Wonder. An incredible cure is waiting to be revealed. A lifesaving medicine is waiting to be invented. A groundbreaking procedure is waiting to be engineered. The whole world is looking to us. And it all starts here. Johns Hopkins inHealth